7Baggers
Quarterly
Annual
    Unit: USD2019-09-30 2019-06-30 2019-03-31 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 
      
    		                 
      cash flows from operating activities:
    		                 
      net income
    		-2,236,000 -1,759,000 -1,989,000 -1,840,228 -1,828,892 -1,495,594 -1,328,657 -1,134,050 -2,545,787 -3,360,033 -4,425,812 -4,360,340 -1,554,969 -1,175,291 -1,126,647 -1,085,615 -1,439,414 
      adjustments to reconcile net income to net cash from operating activities:
    		                 
      depreciation
    		17,000 18,000 17,000  6,991 3,493 2,838 2,598 2,822 -3,899 2,061 3,684 3,686 47,842 -13,750 8,155 21,203 
      recovery of allowance for doubtful accounts
    		-1,000 -4,000 -7,000               
      common stock, restricted stock units and stock options issued to employees, board of directors and consultants for compensation and services
    		139,000 137,000 138,000 109,771 115,459 138,581 254,729 161,907 580,394         
      loss on extinguishment of debt
    		0   38,587 255,685 305,891 89,341 0 304,828         
      change in fair value of contingent consideration
    		0 -4,000 -2,000 -21,645 2,845 1,425 -69,305 -98,979 -27,175         
      amortization of debt discount
    		480,000 447,000 461,000 304,688 229,404 90,456 86,250 88,474 512,874 649,100   370,760     
      amortization of intangible assets
    		179,000 178,000 185,000 157,473 157,475 157,473 157,477 157,473 157,725 110,637 178,082 178,083 157,602     
      changes in operating assets and liabilities, net of acquisition amounts
    		                 
      accounts receivable
    		204,000 -185,000 158,000 -92,108 -126,804 -42,710 -7,192 -7,771 15,922 -3,848 -3,938 23,034 32,208 236,719 -275,186 57,735 5,772 
      prepaid expense and other current assets
    		173,000 -138,000 -458,000 -360,794 29,944 -64,781 88,845 -12,623 101,075         
      inventories
    		110,000 278,000 552,000 -580,453 76,968 -1,085,643 -53,600 -49,815 63,216 -203,084 -174,335 49,993 -17,987     
      operating lease right-of-use asset and liability
    		-7,000 -7,000 -7,000               
      accounts payable and accrued expense
    		703,000 271,000 30,000 351,931 121,948 1,251,064 99,506 286,799 119,702         
      accrued compensation
    		-405,000 71,000 130,000 -846,664 169,916 -82,894 156,552 90,028 186,918 275,737    115,788 125,808 110,719 158,947 
      accrued interest payable
    		43,000 18,000 15,000 15,040 8,023 2,841 7,991 8,298 -22,383 20,931 -45,171 25,470 30,677     
      deferred revenue and customer deposits
    		87,000 -200,000 175,000 -44,819 118,079 24,690 -46,769   0 3,246 0 -16,325     
      net cash from operating activities
    		-514,000 -754,000 -602,000 -2,797,595 -663,138 -815,196 -577,235 -473,657 -495,635 -1,044,786 -995,624 361,641 -105,489 53,642 -359,787 -286,821 -248,304 
      capex
    		-5,000 0 0 13,090 -147,922 -34,505 -2,083 -5,792 -2,256 0 0 0 -6,565 0 0 0 0 
      free cash flows
    		-519,000 -754,000 -602,000 -2,784,505 -811,060 -849,701 -579,318 -479,449 -497,891 -1,044,786 -995,624 361,641 -112,054 53,642 -359,787 -286,821 -248,304 
      cash flows used in investing activities:
    		                 
      purchase of property and equipment
    		-5,000   13,090 -147,922 -34,505 -2,083 -5,792 -2,256         
      asset acquisition
    		0                 
      contingent consideration payment
    		                 
      net cash from investing activities
    		-5,000 -16,000 -343,000   -47,385    -15,538 -150,000       
      cash flows from financing activities:
    		                 
      payments on short-term loans payable
    		-153,000 -434,000 -230,000 -25,578 -32,624 -25,272    0 -71,156 -78,075 -102,920     
      proceeds from short-terms loans payable
    		0 678,000 375,000               
      proceeds from notes payable
    		1,000,000 1,250,000 400,000 0 1,872,500    150,000         
      payments on notes payable
    		-947,000 -1,097,000 -1,615,000 -624,218 -508,630 -212,347 -75,042 -71,270 -67,688 -64,288 -158,256       
      proceeds from sale of common stock and warrants, net of offering costs
    		0 0 2,714,000   0 0 0 3,307,773         
      proceeds from stock option and warrant exercises
    		    2,838,751 0            
      net cash from financing activities
    		-100,000 397,000 1,644,000 -524,796 4,169,997 1,082,381 69,744 -71,270 2,043,310 435,712 2,402,036 -196,061 88,706 8,511 322,021 217,125 329,253 
      net change in cash
    		-619,000 -373,000 699,000 -3,309,301 3,358,937 249,800 -509,574 -550,719 1,545,419 -624,612 1,256,412 165,580 -23,348 619 -37,766 -69,696 80,949 
      cash at beginning of period
    		0 0 1,248,000 0 1,564,859  0 0 829,933  0 0 55,901 -1 0 0 33,374 
      cash at end of period
    		-619,000 -373,000 1,947,000 -3,309,301 4,923,796  -509,574 -550,719 2,375,352  1,256,412 165,580 32,553 618 -37,766 -69,696 114,323 
      supplemental disclosures of cash flow information:
    		                 
      cash paid for interest
    		0 8,000 21,000 0 2,157 0 9,587 13,625 66,719 23,590 118,371 77,550 9,535     
      supplemental disclosures of non-cash investing and financing activities:
    		                 
      common stock issued for conversion of convertible debentures, notes payable and accrued interest
    		0    166,667 515,546            
      relative fair value of common stock issued in connection with notes payable recorded as debt discount and settlement of contingent consideration
    		                 
      fair value of common stock issued to consultants for services
    		53,000                 
      offering costs in connection with warrant exercises included in accounts payable and accrued expense
    		    181,213             
      cumulative adjustment to accumulated deficit for the fair value of the warrant derivative liability upon adoption of asu 2017-11 on january 1, 2018
    		   0 58,609             
      fair value of common stock issued as financing fees in connection with notes payable recorded as debt discount
    		0 28,000 28,000 0 122,500             
      ●
    		                 
      relative fair value of common stock issued in connection with notes payable recorded as debt discount
    		 306,000 61,000  292,129 117,519 55,169   182,203 0       
      purchase of intangible assets
    		  -343,000               
      cash paid for operating lease liabilities
    		  65,000               
      allowance for doubtful accounts
    		     1,977 814 1,698 2,578 1,148 -4,790 0 5,708     
      change in fair value of derivative liabilities
    		     -15,542 -16,055 -3,463 51,656 -697,687 -1,350,688 2,040,909 -57,594     
      deposits
    		                 
      deferred rent
    		                 
      cash flows from investing activities:
    		                 
      acquisitions, net of cash acquired
    		                 
      payment on contingent consideration
    		                 
      proceeds from short-term loans payable
    		         0 0 11,500 10,300     
      proceeds from notes payable and convertible debentures
    		     1,350,000 150,000   500,000 2,657,500       
      issuance of common stock for services
    		                 
      payments on convertible debentures
    		     0 0 0 -1,222,422         
      prepayment penalty on extinguishment of convertible debentures
    		     0 0 0 -127,247         
      cash at beginning of year
    		                 
      cash at end of year
    		                 
      cash paid for income taxes
    		     0 0 3,200 2,400         
      reclassification of the fair value of the embedded conversion features from derivative liability to additional paid-in capital upon conversion
    		     0 0   149,162 944,101       
      offering costs in connection with warrant exercises included in accounts payable and accrued expenses
    		                 
      fair value of non-forfeitable common stock issued to consultant included in accounts payable and accrued expense
    		     0 0           
      fair value of common stock issued for prepayment of future royalties due under the cri license agreement included in prepaid expense and other current assets
    		     0 0           
      proceeds from short-term loans payable for payment of business insurance premiums
    		                 
      depreciation & amortization
    		                 
      (recovery of) allowance for doubtful accounts
    		   0 -179             
      proceeds from warrant and stock option exercises
    		                 
      common stock issued for conversion of convertible debentures and accrued interest
    		       0 350,610         
      reclassification of the fair value of the embedded conversion features from derivativeliability to additional paid-in capital upon conversion
    		                 
      relative fair value of common stock issued in connection with notes payablerecorded as debt discount
    		                 
      issuance of shares of common stock for vested restricted stock units
    		     0 0   87 341 1,591 17,297     
      fair value of non-forfeitable common stock issued to consultant recorded as prepaid expense and other current assets
    		                 
      fair value of embedded conversion feature in convertible debentures in excess of allocated proceeds
    		          1,818,059       
      repayments of line of credit convertible debenture – related party
    		            -42,500     
      financing costs in connection with convertible debentures
    		                 
      proceeds from note payable paid to seller in connection with acquisition
    		         0 0 0 300,000     
      financing costs paid with proceeds from note payable
    		         0        
      cashless exercise of warrants
    		         0 191       
      fair value of the contingent consideration for acquisition
    		         15,521 0 0 314,479     
      reclassification of the fair value of the warrants from derivative liability to additional paid-in capital upon cashless exercise
    		         0 0       
      relative fair value of warrants issued in connection with convertible debentures recorded as debt discount
    		         0 259,077       
      relative fair value of common stock issued in connection with convertible debentures recorded as debt discount
    		         0        
      fair value of embedded conversion feature derivative liabilities recorded as debt discount
    		         0 216,561       
      fair value of warrants issued to placement agents in connection with convertible debentures recorded as debt discount
    		         0        
      fair value of unamortized non-forfeitable common stock issued to consultant included in prepaid expense and other current assets
    		                 
      common stock issued to novalere holdings for payment of the acquisition contingent consideration as a result of an amendment and supplement to the registration rights and stock restriction agreement
    		                 
      fair value of beneficial conversion feature on line of credit convertible debenture – related party
    		         0 0 1,611 1,833     
      relative fair value of common stock issued in connection with convertible debenturesrecorded as debt discount
    		                 
      proceeds from short-term loan payable for payment of d&o insurance premium
    		                 
      proceeds from stock option exercises
    		       0 2,894         
      relative fair value of common stock subscribed but unissued in connection with convertible debentures recorded as debt discount
    		                 
      deferred financing costs included in accounts payable and accrued expense
    		                 
      net proceeds from convertible debentures in escrow included in restricted cash
    		                 
      changes in operating assets and liabilities, net of acquisition amounts:
    		                 
      supplement disclosures of non-cash investing and financing activities:
    		                 
      reclassification of the fair value of the embedded conversion features from derivative       liability to additional paid-in capital upon conversion
    		        203,630         
      relative fair value of common stock issued in connection with notes payable       recorded as debt discount
    		        44,217         
      fair value of non-forfeitable common stock issued to consultant recorded as       prepaid expense and other current assets
    		        15,000         
      fair value of non-forfeitable common stock issued to consultant included in       accounts payable and accrued expense as of december 31, 2016
    		        180,000         
      fair value of common stock issued for prepayment of future royalties due under the      cri license agreement included in prepaid expense and other current assets
    		        44,662         
      fair value of beneficial conversion feature on line of credit convertible debenture –      related party
    		                 
      cash flows from operating activities
    		                 
      gain on purchase price adjustment to goodwill
    		                 
      impairment of goodwill
    		                 
      non-cash gain on settlement of contingent consideration
    		                 
      shares of common stock issued for debt amendment
    		                 
      fair value of embedded conversion feature in convertible  debentures in excess of allocated proceeds
    		                 
      cash flows from investing activities
    		                 
      payments on contingent consideration
    		                 
      cash flows from financing activities
    		                 
      financing costs in connection with issuance of convertible debentures
    		                 
      proceeds from warrant exercises
    		         0        
      proceeds from non-convertible debentures – related party
    		                 
      payments on non-convertible debentures – related party
    		         0        
      supplemental disclosures of cash flow information :
    		                 
      common stock issued for conversion of notes payable, convertible debentures and accrued interest
    		         328,805 1,420,265       
      common stock issued for acquisition
    		                 
      fair value of warrant derivative liabilities recorded as debt discount
    		                 
      fair value of non-forfeitable common stock to be issued to consultant included in prepaid expense and other current assets and accounts payable and accrued expense
    		                 
      return of shares of common stock related to license agreement
    		                 
      accrued interest added to principal in connection with amendment of notes payable
    		                 
      adjustments to reconcile net income to net cash from operating activities
    		                 
      common stock, restricted stock units and stock options issued for services and board compensation
    		          665,896 484,295 739,646     
      stock issued for interest on debt amendment
    		                 
      gain on return of shares of common stock issued in semprae merger
    		                 
      imputed interest on contingent consideration
    		          7,968 16,750 5,584     
      non-cash gain on contingent consideration
    		                 
      prepaid expenses and other current assets
    		                 
      accounts payable and accrued expenses
    		          549,481 208,156 170,407 95,593   101,897 
      payments on beyond human contingent consideration
    		                 
      proceeds from (repayments of) line of credit convertible debenture – related party
    		          -290,192       
      fair value of unamortized non-forfeitable common stock issued to consultant included in prepaid expenses and other current assets
    		                 
      fair value of non-forfeitable common stock to be issued to consultant included in prepaid expenses and other current assets and accounts payable and accrued expenses
    		                 
      common stock issued in connection with debt amendment
    		                 
      amortization of debt discount and deferred financing costs
    		                 
      prepaid expenses
    		           -144 25,108   -24,988 23,155 
      security deposits
    		                 
      purchase of property & equipment
    		           0 -6,565     
      deferred financing costs in connection with convertible debentures
    		                 
      supplemental disclosures of non-cash investing & financing activities:
    		                 
      fair value of warrants issued to placement agents recorded as debt discount
    		                 
      deferred financing costs included in accounts payable and accrued expenses
    		                 
      deferred financing costs paid with proceeds from note payable
    		           0 7,500     
      fair value of unamortized non-forfeitable common stock issued to consultant included in prepaid expenses
    		                 
      cash flows used in investing activities
    		                 
      proceeds from note payable and convertible debentures
    		            242,500     
      payments on note payable
    		            -18,674     
      proceeds from non-convertible debentures - related party
    		                 
      common stock issued for conversion of notes payable
    		                 
      gain of purchase price adjustment to goodwill
    		                 
      amortization of deferred financing costs
    		                 
      net proceeds from (repayments of) line of credit convertible debenture – related party
    		                 
      proceeds from convertible debentures
    		                 
      fees paid in connection with issuance of convertible debentures
    		                 
      payments on notes payable and convertible debentures
    		                 
      payment made on contingent consideration
    		                 
      payments on non-convertible debentures - related party
    		                 
      common stock issued for conversion of debentures – related party
    		                 
      common stock issued for extinguishment of debt
    		                 
      common stock issued for the purchase of vesele
    		                 
      fair value of warrants issued as deferred financing costs
    		                 
      relative fair value of common stock issued in connection with convertible debentures
    		                 
      relative fair value of warrants issued in connection with convertible debentures
    		                 
      exchange of restricted stock units for shares of common stock
    		                 
      adjustments to reconcile net income to net cash used by operating activities
    		                 
      stock based compensation
    		                 
      common stock, stock units and stock options issued for services and board compensation
    		                 
      change in fair value of derivative liability
    		                 
      gain on return of shares issued in semprae merger
    		                 
      excess of fair value of debentures over proceeds on new financing
    		                 
      amortization of intangibles
    		             42,697 27,265   
      inventory
    		             -35,956 -29,199 7,362 -30,315 
      short-term loans, credit cards and other current liabilities
    		                 
      deferred revenue
    		             -99,996 -25,000 -61 -25,288 
      purchase of equipment
    		                 
      intangible assets
    		                 
      proceeds from convertible debenture - related party
    		                 
      proceeds from short-term loans
    		                 
      payments on short-term loans
    		                 
      proceeds from notes payable - related party
    		                25,000 
      payments on notes payable - related party
    		                 
      supplemental disclosures of cash flow information - fair value of:
    		                 
      common stock issued for conversion of debt
    		                 
      common stock issued and issuable for acquisition
    		                 
      common stock and cash potentially issuable for acquisition
    		                 
      share return – semprae acquisition
    		                 
      return of common stock shares related to license agreement
    		                 
      shares issued in conjunction with debt amendment
    		                 
      warrants issued as deferred financing costs
    		                 
      fair value of warrants and conversion feature issued with convertible debentures
    		                 
      see accompanying notes to these condensed consolidated financial statements.
    		                 
      adjustments to reconcile net income to net cash used by operating activities:
    		                 
      stock compensation
    		                564,226 
      common stock, stock units, and stock options issued for services
    		                 
      debt discount
    		                 
      extinguishment of debt
    		                 
      interest payable
    		             17,670 28,593 17,112 22,978 
      acquisition of semprae inc, cash received
    		                 
      proceeds (repayment) from notes payable
    		             0 40,000 0 300,000 
      proceeds from convertible debt
    		             0    
      proceeds from stock issued for cash
    		                 
      proceeds from debentures - related party
    		             0 25,000   
      proceeds from loc convertible debt - related party
    		                 
      repayment of assumed debt related to acquistion of semprae
    		                 
      repayment of dawson james note
    		                 
      supplemental disclosures of cash flow information
    		                 
      common stock of 1,900,000 shares issued for extinguishment of debt
    		             0    
      common stock of 1,855,747 shares issued for conversion of convertible debt
    		             11,507 0 0 742,300 
      common stock of 142,857 shares issued for the purchase of vesele
    		                 
      common stock of 631,313 shares issued with the cri asset purchase agreement
    		                 
      common stock of 83,103 shares issued for conversion of convertible debt
    		                 
      common stock of 3,201,776 shares issued for acquisition of semprae laboratories, inc.
    		                 
      balance at december 31, 2012
    		                 
      common stock issued for services
    		                 
      stock compensation expense
    		                 
      common stock issued for purchase of sensum+ license
    		                 
      common stock sold to related party for cash
    		                 
      common stock issued upon conversion of debt
    		                 
      convertible debt discount
    		                 
      net income for year ended december 31, 2013
    		                 
      balance at december 31, 2013
    		                 
      common stock and options issued for services
    		                 
      common stock issued for product acquisition
    		                 
      common stock issued upon conversion of debt, of which 1,579,297 shares were issued to related parties
    		                 
      convertible debt discount - beneficial conversion feature
    		                 
      convertible debt discount - warrants
    		                 
      net income for year ended december 31, 2014
    		                 
      balance at december 31, 2014
    		                 
      stock-based compensation
    		              282,953   
      fair value of common stock, stock units, and stock options issued for services
    		                 
      prepaid expenses and deposits
    		                 
      proceeds from convertible debt - related party
    		              207,021 117,125 4,253 
      accounts payable and accrueds
    		                 
      supplemental disclosures of
    		                 
      cash flow information
    		                 
      adjustments to reconcile net income to
    		                 
      net cash used by operating activities:
    		                 
      common stock and stock units issued for services
    		                153,754 
      debt discount write-off in connection with conversion of notes payable
    		                143,612 
      accretion of debt discount
    		                41,832 
      amortization expense
    		                9,337 
      3
    		                 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.